Top Story

Top five dermatology stories in July include psoriasis studies, FDA approval

July 31, 2017

Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles in July on

Other widely-read articles included the FDA’s approval of Tremfya for treating adults with moderate-to-severe psoriasis who are candidates for systemic therapy or phototherapy, and research finding that patients with lung cancer who received immunotherapy experienced hair repigmentation:

Five recent developments in melanoma

July 12, 2017
Study findings that pathologists had lower levels of accuracy and reproducibility in diagnosing some melanomas when compared with other types of melanoma was among…
In the Journals

Bullous pemphigoid showed possible link to hematologic malignancy

July 11, 2017
Bullous pemphigoid demonstrated some association with hematologic malignancy despite showing no association with overall malignancy. In the current meta-analysis…

FDA approval, atopic dermatitis study top dermatology reads for week

June 26, 2017
The FDA’s approval of Baxdela for treating acute bacterial skin and skin structure infections was among the top read articles of the past week on…
More Headlines »